A detailed history of Cullen/Frost Bankers, Inc. transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Cullen/Frost Bankers, Inc. holds 28,996 shares of TMO stock, worth $15.4 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
28,996
Previous 27,831 4.19%
Holding current value
$15.4 Million
Previous $15.4 Million 16.53%
% of portfolio
0.25%
Previous 0.23%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$531.86 - $624.21 $619,616 - $727,204
1,165 Added 4.19%
28,996 $17.9 Million
Q2 2024

Aug 05, 2024

BUY
$541.52 - $599.02 $413,721 - $457,651
764 Added 2.82%
27,831 $15.4 Million
Q1 2024

May 10, 2024

SELL
$528.82 - $599.43 $493,389 - $559,268
-933 Reduced 3.33%
27,067 $15.7 Million
Q4 2023

Feb 06, 2024

BUY
$431.41 - $532.94 $542,282 - $669,905
1,257 Added 4.7%
28,000 $14.9 Million
Q3 2023

Nov 02, 2023

BUY
$498.29 - $574.41 $237,186 - $273,419
476 Added 1.81%
26,743 $13.5 Million
Q2 2023

Aug 04, 2023

BUY
$508.46 - $591.13 $1.05 Million - $1.22 Million
2,056 Added 8.49%
26,267 $13.7 Million
Q1 2023

May 05, 2023

BUY
$535.0 - $604.82 $946,415 - $1.07 Million
1,769 Added 7.88%
24,211 $14 Million
Q4 2022

Feb 13, 2023

BUY
$484.71 - $571.37 $1.83 Million - $2.16 Million
3,783 Added 20.27%
22,442 $12.4 Million
Q3 2022

Nov 07, 2022

BUY
$507.19 - $604.49 $87,743 - $104,576
173 Added 0.94%
18,659 $9.47 Million
Q2 2022

Aug 05, 2022

SELL
$500.9 - $612.21 $158,284 - $193,458
-316 Reduced 1.68%
18,486 $10 Million
Q1 2022

May 09, 2022

BUY
$524.0 - $644.92 $26,200 - $32,245
50 Added 0.27%
18,802 $11.1 Million
Q4 2021

Feb 07, 2022

SELL
$569.0 - $667.24 $308,398 - $361,644
-542 Reduced 2.81%
18,752 $12.5 Million
Q3 2021

Nov 04, 2021

BUY
$509.53 - $609.78 $5.09 Million - $6.09 Million
9,988 Added 107.33%
19,294 $11 Million
Q2 2021

Aug 05, 2021

SELL
$441.0 - $508.24 $20,286 - $23,379
-46 Reduced 0.49%
9,306 $4.7 Million
Q1 2021

May 05, 2021

BUY
$439.85 - $518.83 $112,161 - $132,301
255 Added 2.8%
9,352 $4.27 Million
Q4 2020

Feb 08, 2021

SELL
$435.06 - $527.66 $55,687 - $67,540
-128 Reduced 1.39%
9,097 $4.24 Million
Q3 2020

Nov 05, 2020

SELL
$359.77 - $441.52 $257,235 - $315,686
-715 Reduced 7.19%
9,225 $4.07 Million
Q2 2020

Aug 05, 2020

BUY
$275.2 - $362.34 $2.59 Million - $3.41 Million
9,420 Added 1811.54%
9,940 $3.6 Million
Q1 2020

May 01, 2020

SELL
$255.3 - $340.05 $18,381 - $24,483
-72 Reduced 12.16%
520 $147,000
Q4 2019

Feb 06, 2020

BUY
$271.93 - $328.04 $84,842 - $102,348
312 Added 111.43%
592 $192,000
Q3 2019

Nov 01, 2019

SELL
$268.46 - $305.43 $28,188 - $32,070
-105 Reduced 27.27%
280 $82,000
Q2 2019

Aug 01, 2019

BUY
$257.51 - $295.55 $38,884 - $44,628
151 Added 64.53%
385 $113,000
Q1 2019

Apr 30, 2019

BUY
$212.17 - $273.72 $49,647 - $64,050
234 New
234 $64,000
Q2 2018

Jul 27, 2018

SELL
$203.14 - $219.53 $212,078 - $229,189
-1,044 Closed
0 $0
Q1 2018

May 11, 2018

SELL
$192.98 - $224.11 $27,982 - $32,495
-145 Reduced 12.2%
1,044 $216,000
Q4 2017

Jan 31, 2018

SELL
$182.03 - $200.37 $25,302 - $27,851
-139 Reduced 10.47%
1,189 $226,000
Q3 2017

Nov 02, 2017

BUY
$171.74 - $194.04 $228,070 - $257,685
1,328
1,328 $251,000

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $208B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Cullen/Frost Bankers, Inc. Portfolio

Follow Cullen/Frost Bankers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.